Imprimis acquires second pharmacy • 9:43 AM
Douglas W. House, SA News Ed...
- In a all-stock transaction, Imprimis Pharmaceuticals (IMMY) acquires South Coast Specialty Compounding. As part of the transaction, Park signs a license agreement allowing it to immediately begin making and dispensing Imprimis' ophthalmology and urology formulations in the 13 states where it is currently licensed, including CA, NV, OR and HI.
- Park will generate almost $4M in top line revenue in 2014.
- Imprimis acquired its first pharmacy, Pharmacy Creations, LLC, in April 2014.
IMMY price at time of publication: $8.40. Check IMMY price now »
No comments:
Post a Comment